📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial (2022)

First Author: Amuge Pauline

Attributed to: Blood borne viruses funded by MRC

Abstract

No abstract provided

Bibliographic Information

Type: Journal Article/Review

Volume: 9

Parent Publication: LANCET HIV

Issue: 9

ISSN: 2352-3018